These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6627214)

  • 1. Preradiation chemotherapy for newly diagnosed childhood brain tumors. A modified Phase II trial.
    Allen JC; Helson L; Jereb B
    Cancer; 1983 Dec; 52(11):2001-6. PubMed ID: 6627214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
    Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
    J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system.
    Allen JC; Kim JH; Packer RJ
    J Neurosurg; 1987 Jul; 67(1):65-70. PubMed ID: 2439668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive disease in children with medulloblastoma/PNET during preradiation chemotherapy.
    Tornesello A; Mastrangelo S; Piciacchia D; Bembo V; Colosimo C; Di Rocco C; Mastrangelo R
    J Neurooncol; 1999; 45(2):135-40. PubMed ID: 10778729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.
    Kovnar EH; Kellie SJ; Horowitz ME; Sanford RA; Langston JW; Mulhern RK; Jenkins JJ; Douglass EC; Etcubanas EE; Fairclough DL
    J Clin Oncol; 1990 Feb; 8(2):330-6. PubMed ID: 2153766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.
    Duffner PK; Horowitz ME; Krischer JP; Friedman HS; Burger PC; Cohen ME; Sanford RA; Mulhern RK; James HE; Freeman CR
    N Engl J Med; 1993 Jun; 328(24):1725-31. PubMed ID: 8388548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children.
    Allen JC; Helson L
    J Neurosurg; 1981 Nov; 55(5):749-56. PubMed ID: 7310496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuraxis dissemination in pediatric brain tumors. Response to preirradiation chemotherapy.
    Kellie SJ; Kovnar EH; Kun LE; Horowitz ME; Heideman RL; Douglass EC; Langston JW; Sanford RA; Jenkins JJ; Fairclough DL
    Cancer; 1992 Feb; 69(4):1061-6. PubMed ID: 1735073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88/'89.
    Kühl J; Müller HL; Berthold F; Kortmann RD; Deinlein F; Maass E; Graf N; Gnekow A; Scheurlen W; Göbel U; Wolff JE; Bamberg M; Kaatsch P; Kleihues P; Rating D; Sörensen N; Wiestler OD
    Klin Padiatr; 1998; 210(4):227-33. PubMed ID: 9743957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
    Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.
    Graham ML; Herndon JE; Casey JR; Chaffee S; Ciocci GH; Krischer JP; Kurtzberg J; Laughlin MJ; Longee DC; Olson JF; Paleologus N; Pennington CN; Friedman HS
    J Clin Oncol; 1997 May; 15(5):1814-23. PubMed ID: 9164190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
    Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
    J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
    J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
    Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D;
    Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study.
    Mahoney DH; Strother D; Camitta B; Bowen T; Ghim T; Pick T; Wall D; Yu L; Shuster JJ; Friedman H
    J Clin Oncol; 1996 Feb; 14(2):382-8. PubMed ID: 8636747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult medulloblastoma: multiagent chemotherapy.
    Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
    Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.
    Pendergrass TW; Milstein JM; Geyer JR; Mulne AF; Kosnik EJ; Morris JD; Heideman RL; Ruymann FB; Stuntz JT; Bleyer WA
    J Clin Oncol; 1987 Aug; 5(8):1221-31. PubMed ID: 3040919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.